Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues

Molecular and Cellular Biology

Volumn 24, Issue 17, 2004, Pages 7538-7547

  De Marval, Paula L Miliani ^a   Macias, Everardo ^a   Rounbehler, Robert ^b   Sicinski, Piotr ^c   Kiyokawa, Hiroaki ^d   Johnson, David G ^b   Conti, Claudio J ^b   Rodriguez Puebla, Marcelo L ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; MYC PROTEIN; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EPIDERMIS; EPITHELIUM; FEMALE; GENE EXPRESSION; IN VIVO STUDY; KERATINOCYTE; MALE; MOUSE; MOUTH TUMOR; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; SKIN TUMOR; TRANSGENIC MOUSE;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; EPIDERMIS; EPITHELIUM; HUMANS; KERATINOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; MUS MUSCULUS;

EID: 4344631708     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.17.7538-7547.2004     Document Type: Article

References (76)

1. Adams, J. M., A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinster. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533-538.
2. Akervall, J., U. Bockmuhl, I. Petersen, K. Yang, T. E. Carey, and D. M. Kurnit. 2003. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck. Clin. Cancer Res. 9:1750-1755.
3. Amati, B., and H. Land. 1994. Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr. Opin. Genet. Dev. 4:102-108.
4. An, H., M. W. Beckmann, G. Reifenger, H. G. Bender, and D. Niederacher. 1999. Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation. Am. J. Pathol. 154:113-118.
5. Askew, D., R. Ashmun, B. Simmons, and J. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922.
6. Augenlicht, L. H., S. Wadler, G. Corner, C. Richards, L. Ryan, A. S. Multani, S. Pathak, A. Benson, D. Haller, and B. G. Heerdt. 1997. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial. Cancer Res. 57:1769-1775.
7. Baudino, T. A., and J. L. Cleveland. 2001. The Max network gone mad. Mol. Cell. Biol. 21:691-702.
8. Baudino, T. A., K. H. Maclean, J. Brennan, E. Parganas, C. Yang, A. Aslanian, J. A. Lees, C. J. Sherr, M. F. Roussel, and J. L. Cleveland. 2003. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2F1 loss. Mol. Cell 11:905-914.
9. Bello-Fernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804-7808.
10. Bemark, M., and M. Neuberger. 2000. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line. Oncogene 13:3404-3410.
11. Berthet, C., E. Aleem, V. Coppola, L. Tassarollo, and P. Kaldis. 2003. Cdk2 knockout mice are viable. Curr. Biol. 13:1775-1785.
12. Bishop, J. M., M. Eilers, A. L. Katzen, T. Kornberg, G. Ramsay, and S. Schirm. 1991. MYB and MYC in the cell cycle. Cold Spring Harbor Symp. Quant. Biol. 56:99-107.
13. Bitzer, M., M. Stahl, J. Arjumand, M. Rees, B. Klump, H. Heep, H. E. Gabbert, and M. Sarbia. 2003. c-Myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality. Anticancer Res. 23:1489-1493.
14. Bouchard, C., K. Thieke, A. Maier, R. Saffrich, J. Hanley-Hyde, W. Ansorge, S. Reed, P. Sicinski, J. Bartek, and M. Eilers. 1999. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18:5321-5333.
15. Cullen, J. M., B. H. Ruebner, D. P. Hsieh, and E. J. Burkes, Jr. 1987. Odontogenic tumors in Fischer rats. J. Oral Pathol. 16:469-473.
16. Daksis, J. L, R. Y. Lu, L. M. Facchini, W. W. Marhin, and L. J. Penn. 1994. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 9:3635-3645.
17. Dang, C. V. 1999. c-myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1-11.
18. Dang, C. V., L. M. Resar, E. Emison, S. Kim, Q. Li, J. E. Prescott, D. Wonsey, and K. Zeller. 1999. Function of the c-Myc oncogenic transcription factor. Exp. Cell Res. 253:63-77.
19. Datar, S. A., H. W. Jacobs, A. F. de la Cruz, C. F. Lehner, and B. A. Edgar. 2000. The Drosophila cyclin D-Cdk4 complex promotes cellular growth. EMBO J. 19:4543-4554.
20. Dayan, D., T. Waner, A. Harmelin, and A. Nyska. 1984. Bilateral complex odontoma in a Swiss (CD-1) male mouse. Lab. Anim. 28:90-92.
21. Downs, K. M., G. R. Martin, and J. M. Bishop. 1989. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 3:860-869.
22. Eilers, M., S. Schirm, and J. M. Bishop. 1991. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10:133-141.
23. Erisman, M. D., P. G. Rothberg, R. E. Diehl, C. C. Morse, J. M. Spandorfer, and S. M. Astrin. 1985. Deregulation of c-myc gene expression in human colon carcinoma is not accompanied by amplification or rearrangement of the gene. Mol. Cell. Biol. 5:1969-1976.
24. Evan, G., A. Wyllie, C. Gilbert, T. Littlewood, H. Land, M. Brooks, C. Waters, L. Penn, and D. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
25. Facchini, L. M., and L. Penn. 1998. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12:633-651.
26. Field, J. K., D. A. Spandidos, P. M. Stell, E. D. Vaughan, G. I. Evan, and J. P. Moore. 1989. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma. Oncogene 4:1463-1468.
27. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517.
28. Gardner, D. G. 1992. An orderly approach to the study of odontogenic tumors in animals. J. Comp. Pathol. 107:427-438.
29. Gaubatz, S., A. Meichle, and M. Eilers. 1994. An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc. Mol. Cell. Biol. 14:3853-3862.
30. Gibson, C. W., E. Lally, R. C. Herold, S. Decker, R. L. Brinster, and E. P. Sandgren. 1992. Odontogenic tumors in mice carrying albumin-myc and albumin-rats transgenes. Calcif. Tissue Int. 51:162-167.
31. Grandori, C., and R. N. Eisenman. 1997. Myc target genes. Trends Biochem. Sci. 22:177-181.
32. Haas, K., P. Staller, C. Geisen, J. Bartek, M. Eilers, and T. Moroy. 1997. Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc. Oncogene 15:179-192.
33. Hanson, K. D., M. Shichiri, M. R. Follansbee, and J. M. Sedivy. 1994. Effects of c-myc ntyc expression on cell cycle progression. Mol. Cell. Biol. 14:5748-5755.
34. He, J., J. R. Allen, V. P. Collins, M. J. Allalunis-Turner, R. Godbout, R. S. Day, and C. D. James. 1994. CDK4 amplification is an alternative mechanism to p16 homozygous deletion in glioma cell lines. Cancer Res. 54:5804-5807.
35. Henriksson, M., B. Lüscher, and A. Pardee. 1996. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68:109-182.
36. Hermeking, H., C. Rago, M. Schuhmacher, Q. Li, J. Barret, A. Obaya, B.] O'Connell, M. Mateyak, W. Tam, F. Kolhlhuber, C. Dang, J. Sedivy, D. Eick, B. Vogelstein, and K. Kinzler. 2000. Identification of CDK4 as a target of c-Myc. Proc. Natl. Acad. Sci. USA 97:2229-2234.
37. Hoang, A. T., K. J. Cohen, J. F. Barrett, D. A. Bergstrom, and C. V. Dang. 1994. Participation of cyclin A in Myc-induced apoptosis. Proc. Natl. Acad. Sci. USA 91:6875-6879.
38. Jansen-Durr, P., A. Meichle, P. Steiner, M. Pagano, K. Finke, J. Botz, J. Wessbecher, G. Draetta, and M. Eilers. 1993. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA 90:3685-3689.
39. Kanoe, H., T. Nakayama, H. Murakami, T. Hosaka, H. Yamamoto, Y. Nakashima, T. Tsuboyama, T. Nakamura, M. Sasaki, and J. Toguchida. 1998. Amplification of CDK4 gene in sarcomas: tumor specificity and relationship with the Rb mutation. Anticancer Res. 18:2317-2321.
40. Little, C. D., M. M. Nau, D. N. Carney, A. F. Gazdar, and J. D. Minna. 1983. Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306:194-196.
41. Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. Myc function and regulation. Annu. Rev. Biochem. 61:809-860.
42. Mariani-Costantini, R., C. Escot, C. Theillet, A. Gentile, G. Merlo, R. Lidereau, and R. Callahan. 1988. In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast. Cancer Res. 48:199-205.
43. Martin, J., S. L. Hunt, P. Dubus, R. Sotillo, F. Nehme-Pelluard, M. A. Magnuson, A. F. Parlow, M. Malumbres, S. Ortega, and M. Barbacid. 2003. Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number. Oncogene 22:5261-5269.
44. Melchle, A., A. Philipp, and M. Eilers. 1992. The functions of Myc proteins. Biochim. Biophys. Acta 1114:129-146.
45. Meyer, C. A., H. W. Jacobs, S. A. Datar, W. Du, B. A. Edgar, and C. F. Lehner. 2000. Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression. EMBO J. 19:4533-4542.
46. Miliani de Marval, P., I. Gimenez-Conti, M. LaCava, L. Martinez, C. Conti, and M. Rodriguez-Puebla. 2001. Transgenic expression of CDK4 results in epidermal hyperplasia and severe dermal fibrosis. Am. J. Pathol. 159:369-379.
47. Miliani de Marval, P. L., E. Macias, C. J. Conti, and M. L. Rodriguez-Puebla. 2004. Enhanced malignant tumorigenesis in Cdk4 transgenic mice. Oncogene 23:1863-1873.
48. Moreno de Alboran, I., R. O'Hagan, F. Gartner, B. Malynn, L. Davidson, R. Rickert, K. Rajewsky, and R. DePinho. 2001. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 14:45-55.
49. Muller, D., C. Bouchard, B. Rudolph, P. Steiner, I. Stuckmann, R. Saffrich, W. Ansorge, W. Huttner, and M. Eilers. 1997. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene 15:2561-2576.
50. O'Hagan, R. C., M. Ohh, G. David, I. M. de Alboran, F. W. Alt, W. G. Kaelin, Jr., and R. A. DePinho. 2000. Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression. Genes Dev. 14: 2185-2191.
51. Ortega, S., I. Prieto, J. Odajima, A. Martin, P. Dubus, R. Sotillo, J. L. Barbero, M. Malumbres, and M. Barbacid. 2003. Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice. Nat. Genet. 35:25-31.
52. Pelengaris, S., T. Littlewood, M. Khan, G. Elia, and G. Evan. 1999. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol. Cell 3:565-577.
53. Perez-Roger, I., S. H. Kim, B. Griffiths, A. Sewing, and H. Land. 1999. Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). EMBO J. 18:5310-5320.
54. Perez-Roger, I., D. L. Solomon, A. Sewing, and H. Land. 1997, Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene 14: 2373-2381.
55. Rane, S. G., S. Cosenza, R. V. Mettus, and E. P. Reddy. 2002. Germ line transmission of the Cdk4R24C mutation facilitates tumorigenesis and escape from cellular senescence. Mol. Cell. Biol. 22:644-656.
56. Rane, S. G., P. Dubus, R. V. Mettus, E. J. Galbreath, G. Boden, E. Premkumar Reddy, and M. Barbacid. 1999. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in B-islet cell hyperplasia. Nat. Genet. 22:44-52.
57. Robles, A., M. Rodriguez-Puebla, A. Glick, C. Trempus, L. Hansen, P. Sicinski, R. Tennant, R. Weinberg, S. Yuspa, and C. Conti. 1998. Reduced skin tumor development in cyclin D1 deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev. 12:2469-2474.
58. Rodriguez-Puebla, M. L., P. L. Miliani de Marval, M. LaCava, D. S. Moons, H. Kiyokawa, and C. J. Conti. 2002. Cdk4 deficiency inhibits skin tumor development but does not affect keratinocyte proliferation. Am. J. Pathol. 161:405-411.
59. Rodriguez-Puebla, M. L., A. I. Robles, and C. J. Conti. 1999. Ras activity and cyclin D1 expression: an essential mechanism of mouse skin tumor development. Mol. Carcinogenesis 24:1-6.
60. Rounbehler, R. J., P. M. Rogers, C. J. Conti, and D. G. Johnson. 2002. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Cancer Res. 62:3276-3281.
61. Rounbehler, R. J., R. Schneider-Broussard, C. J. Conti, and D. G. Johnson. 2001. Myc lacks E2F1's ability to suppress skin carcinogenesis. Oncogene 20:5341-5349.
62. Sears, R., G. Leone, J. DeGregori, and J. R. Nevins. 1999. Ras enhances Myc protein stability. Mol. Cell 3:169-179.
63. Sears, R., F. Nuckolls, E. Haura, Y. Taya, K. Tamai, and J. R. Nevins. 2000. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 14:2501-2514.
64. Sicinski, P., J. Donaher, Y. geneg, S. Parker, H. Garder, M. Park, R. Robker, J. Richards, L. McGinnis, J. Biggers, J. Epping, R. Bronson, S. Elledege, and R. Weinberg. 1996. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470-474.
65. Sotillo, R., P. Dubus, J. Martin, E. de la Cueva, S. Ortega, M. Malumbres, and M. Barbacid. 2001. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J. 20:6637-6647.
66. Tetsu, O., and F. McCormick. 2003. Proliferation of cancer cells despite CDK2 inhibition. Cancer Cells 3:233-245.
67. Kip1 activity. Mol. Cell. Biol. 19:7011-7019.
68. Vlach, J., S. Hennecke, K. Alevizopoulos, D. Conti, and B. Amati. 1996. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J. 15:6595-6604.
69. Waikel, R. L., Y. Kawachi, P. A. Waikel, X. J. Wang, and D. R. Roop. 2001. Deregulated expression of c-Myc depletes epidermal stem cells. Nat. Genet, 28:165-168.
70. Waikel, R. L., X. J. Wang, and D. R. Roop. 1999. Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis. Oncogene 18:4870-4878.
71. Walsh, K. M., L. J. Denholm, and B. J. Cooper. 1987. Epithelial odontogenic tumours in domestic animals. J. Comp. Pathol. 97:503-521.
72. Waters, C., T. Littlewood, D. Hancock, J. Moore, and G. J. Evan. 1991. c-Myc protein expression in untransformed fibroblasts. Oncogene 6:797-805.
73. Wölfel, T., M. Hauer, J. Schneider, M. Serrano, C. Wölfel, E. Klehmann-Hieb, E. De Plaen, T. Hankeln, K. H. Meyer zum Büschenfelde, and D. Beach. 1995. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269:1281-1284.
74. Yu, Q., Y. Geng, and P. Sicinski. 2001. Specific protection against breast cancers by cyclin D1 ablation. Nature 411:1017-1021.
75. Zou, X., D. Ray, A. Aziyu, K. Christov, A. D. Boiko, A. V. Gudkov, and H. Kiyokawa. 2002. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence. Genes Dev. 16:2923-2934.
76. Zuo, L. 1996. Germline mutation in the p16Ink4a binding domain of cdk4 in familial melanoma. Nat. Genet. 12:97-99.